Compare PCRX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | CYH |
|---|---|---|
| Founded | 2006 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 411.7M |
| IPO Year | 2010 | 2000 |
| Metric | PCRX | CYH |
|---|---|---|
| Price | $24.68 | $2.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $30.25 | $3.28 |
| AVG Volume (30 Days) | 406.9K | ★ 862.4K |
| Earning Date | 04-30-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 107.44 | ★ 196.67 |
| EPS | ★ 0.19 | 0.09 |
| Revenue | $541,533,000.00 | ★ $12,485,000,000.00 |
| Revenue This Year | $6.78 | N/A |
| Revenue Next Year | $8.54 | $2.17 |
| P/E Ratio | $133.47 | ★ $32.44 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $2.41 |
| 52 Week High | $27.66 | $4.43 |
| Indicator | PCRX | CYH |
|---|---|---|
| Relative Strength Index (RSI) | 51.58 | 49.34 |
| Support Level | $21.97 | $2.82 |
| Resistance Level | $26.93 | $3.00 |
| Average True Range (ATR) | 0.61 | 0.08 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 39.24 | 73.81 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.